Risperidone appears safe in patients with antipsychotic-induced blood dyscrasias.

Mahmood T, Silverstone T, Spittle B

DOI: 10.1097/00004850-199603000-00007
Published: 1996 Mar
Container: International clinical psychopharmacology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/00004850-199603000-00007,
  title = {Risperidone appears safe in patients with antipsychotic-induced blood dyscrasias.},
  author = {Mahmood T and Silverstone T and Spittle B},
  year = {1996},
  journal = {International clinical psychopharmacology},
  doi = {10.1097/00004850-199603000-00007},
  url = {https://doi.org/10.1097/00004850-199603000-00007}
}

RIS

TY  - JOUR
TI  - Risperidone appears safe in patients with antipsychotic-induced blood dyscrasias.
AU  - Mahmood T
AU  - Silverstone T
AU  - Spittle B
PY  - 1996
JO  - International clinical psychopharmacology
DO  - 10.1097/00004850-199603000-00007
UR  - https://doi.org/10.1097/00004850-199603000-00007
ER  -

APA

T, M., T, S., & B, S. (1996). Risperidone appears safe in patients with antipsychotic-induced blood dyscrasias.. International clinical psychopharmacology. https://doi.org/10.1097/00004850-199603000-00007

Source records

pubmed · retrieved 2026-09-25T15:28:40.082Z
europe-pmc · retrieved 2026-09-25T15:28:40.112Z